news 2020

« BACK

Pharmacology



Results 1 - 9 of 9.


Pharmacology - Health - 23.03.2020
IOR lays the foundation for a new clinical trial against lymphomas
IOR lays the foundation for a new clinical trial against lymphomas
A study conducted by med. Francesco Bertoni at the Institute of Oncology Research ( IOR , affiliated to USI) has shown that a specific combination of drugs is a potentially winning strategy in the fight against lymphomas. The results obtained in the laboratory have enabled the researchers at the Istituto Oncologico della Svizzera italiana ( IOSI ) to develop a clinical study together with the Swiss Group for Clinical Cancer Research ( SAKK ).

Health - Pharmacology - 09.03.2020
Circulatory failure is predictable
Circulatory failure is predictable
Researchers at ETH Zurich and Bern University Hospital have developed a method for predicting circulatory failure in patients in intensive care units - enabling clinicians to intervene at an early stage. Their approach uses machine learning methods to evaluate an extensive body of patient data. Patients in a hospital's intensive care unit are kept under close observation: clinicians continuously monitor their vital signs such as their pulse, blood pressure and blood oxygen saturation.

Health - Pharmacology - 21.02.2020
A better diagnosis of rare diabetes to adapt treatment
A better diagnosis of rare diabetes to adapt treatment
Scientists highlight the importance of monogenic diabetes and the consequences in terms of care of a precise diagnosis. Diabetes affects more than 400 million people worldwide and is a major public health problem. Although commonly referred to as a single disease, it actually constitutes a group of metabolic disorders with hyperglycaemia as a common feature.

Health - Pharmacology - 20.02.2020
Decision time predicts the risk of depression relapse
Decision time predicts the risk of depression relapse
In a study, researchers have shown that it is possible to predict the risk of relapsing into depression after stopping antidepressant medication. People who relapse take longer to decide how much effort to invest for a reward. Depressive disorder is a major public health problem with an unpredictable course.

Pharmacology - Health - 10.02.2020
Personalized cancer vaccines
Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials. EPFL researchers are currently working on an alternative. They have developed a platform that allows a cancer vaccine to be delivered to a precise location and stimulate the immune system in a safe way - thereby overcoming one of the two obstacles to creating an effective vaccine.

Pharmacology - Health - 06.02.2020
New Understanding of Childhood Immune Systems May Improve Vaccine Efficacy
New Understanding of Childhood Immune Systems May Improve Vaccine Efficacy
In lowand middle-income countries, children have the greatest need for protection afforded by vaccination due to a higher incidence of infectious diseases. However, the vaccines for these children often show a lower efficacy when compared to similar populations in high-income settings. A new study by the Swiss Tropical and Public Health Institute (Swiss TPH) and partners from the Babraham Institute, ISGlobal and others published yesterday in Science Translational Medicine reveals that the immune system of children varies according to age, location and anaemia status.

Pharmacology - Health - 03.02.2020
Designing an emergency stop switch for immunotherapies
Designing an emergency stop switch for immunotherapies
CAR T-cell therapy is a highly promising treatment strategy for tumors, but is associated with life-threatening side effects. Researchers at EPFL, UNIL and CHUV have developed a new way to "switch off" the therapy when a cancer patient's life is in danger, paving the way for safer immunotherapy approaches to target solid tumors.

Health - Pharmacology - 20.01.2020
Refining Breast Cancer Classification by Multiplexed Imaging
Refining Breast Cancer Classification by Multiplexed Imaging
An imaging approach developed at UZH enables the study of breast cancer tissue in greater detail. It uses 35 biomarkers to identify the different cell types in breast tumors and its surrounding area compared to the current standard of testing single markers. This increases the precision of tumor analysis and classification - and improves personalized diagnostics for breast cancer patients.

Health - Pharmacology - 13.01.2020
Reducing the risk of blood clots in artificial heart valves
Reducing the risk of blood clots in artificial heart valves
People with mechanical heart valves need blood thinners on a daily basis, because they have a higher risk of blood clots and stroke. Researchers at the ARTORG Center of the University of Bern, Switzerland, now identified the root cause of blood turbulence leading to clotting. Design optimization could greatly reduce the risk of clotting and enable these patients to live without life-long medication.